JOHNSON & JOHNSON revenue breakdown overview

JOHNSON & JOHNSON revenue for the last year amounted to 71.70 B CHF, the most of which — 46.10 B CHF — came from its highest performing source at the moment, Innovative Medicine, the year earlier bringing 48.61 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought JOHNSON & JOHNSON 39.10 B CHF, and the year before that — 44.92 B CHF.